Myopia is the clinical term for nearsightedness. Patients with myopia see distance objects clearly, while things that are nearby appear blurry. Myopia usually results from the eye being too long. The eye tends to grow longer as we grow through childhood, often resulting in the need for stronger glasses. Genetics play an important role in myopia. Children with parents who are nearsighted have an increased risk of becoming nearsighted themselves
Risk factors for myopia progression include:
Myopia treatments have been shown to reduce a person’s myopia progression by up to 60 percent. Myopia has been associated with cataracts, primary open angle glaucoma and retinal detachments. The risk of developing these conditions increases as myopia increases. Reducing a person’s myopia could also decrease his or her chances of developing one of these vision-threatening diseases.
MiSight is a daily disposable, soft contact lens that fits and feels like a regular contact lens. It not only corrects distance vision, but has the added benefit of being clinically proven (and FDA approved) to slow the progression of myopia in children by an average of 59%.
Ortho-K contact lenses are worn over night during sleep and are removed in the morning. These lenses temporarily change the shape of the cornea so that a person can see clearly throughout the day without the need for glasses or contact lenses.
Atropine 1% is an eye drop that typically makes the pupil larger; resulting in increased sensitivity to light and blurred near vision. Low concentration (0.01%, 0.02%, and 0.05%) atropine has been shown to slow myopia progression without significantly increasing pupil size or affecting near vision.